Colleen Carey

Colleen Carey

Auto-generated profile, based on publicly available information

Colleen Carey

Department of Economics and Brooks School of Public Policy, Cornell University , Ithaca, NY 14853

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Health Affairs
Verified
Journal Article
Closed access
PDF file
BSBenjamin D. Sommers
Benjamin D. Sommers
TBThomas Buchmueller
Thomas Buchmueller
SDSandra L. Decker
Sandra L. Decker
CCColleen Carey
Colleen Carey
RKRichard Kronick
Richard Kronick
The Affordable Care Act enables young adults to remain as dependents on their parents’ health insurance until age twenty-six, and recent evidence suggests that as many as three million young adults have gained coverage as a result. However, there has been no evidence yet on the policy’s effect on access to care, and questions remain about the coverage impact on important subgroups. Using data from two nationally representative surveys, comparing young adults who gained access to dependent coverage to a control group (adults ages 26–34) who were not affected by the new policy, we found sizable coverage gains for adults ages 19–25. The gains continued to grow throughout 2011 (up 6.7 percentage points from September 2010 to September 2011), with the largest gains seen in unmarried adults, nonstudents, and men. Analysis of the timing of the policy impact suggested that early gains in coverage were greatest for people in worse health. We found strong evidence of increased access to care because of the law, with significant reductions in the number of young adults who delayed getting care and in those who did not receive needed care because of cost.

1 February 2018 in American Economic Journal: Economic Policy
Verified
Journal Article
Closed access
PDF file
TBThomas C. Buchmueller
Thomas C. Buchmueller
CCColleen Carey
Colleen Carey
The misuse of prescription opioids has become a serious epidemic in the United States. In response, states have implemented Prescription Drug Monitoring Programs (PDMPs), which record a patient’s opioid prescribing history. While few providers participated in early systems, states have recently begun to require providers to access the PDMP under certain circumstances. We find that “must access” PDMPs significantly reduce measures of misuse in Medicare Part D. In contrast, we find that PDMPs without such provisions have no effect. We find stronger effects when providers are required to access the PDMP under broad circumstances, not only when they are suspicious. (JEL H75, I11, I12, I18)

19 June 2018 in Annals of Internal Medicine
Verified
Journal Article
Closed access
CCColleen M. Carey
Colleen M. Carey
AJAnupam B. Jena
Anupam B. Jena
MBMichael L. Barnett
Michael L. Barnett
Providers are increasingly being expected to examine their patients' opioid treatment histories before writing new opioid prescriptions. This study uses data from 2008 to 2012 from a 5% sample of M... Background: Providers are increasingly being expected to examine their patients' opioid treatment histories before writing new opioid prescriptions. However, little evidence exists on how patterns ...

1 May 2007 in Pediatrics
Verified
Journal Article
Closed access
PDF file
PCPaul J. Chung
Paul J. Chung
CGCraig F. Garfield
Craig F. Garfield
MEMarc N. Elliott
Marc N. Elliott
CCColleen Carey
Colleen Carey
CECarl Eriksson
Carl Eriksson
MSMark A. Schuster
Mark A. Schuster
OBJECTIVE. Parents of children with special health care needs are especially vulnerable to work–family conflicts that family leave benefits might help resolve. We examined leave-taking among full-time–employed parents of children with special health care needs.METHODS. We identified all children with special health care needs in 2 large inpatient/outpatient systems in Chicago, Illinois, and Los Angeles, California, and randomly selected 800 per site. From November 2003 to January 2004, we conducted telephone interviews with 1105 (87% of eligible and successfully contacted) parents. Among the sample's 574 full-time–employed parents, we examined whether leave benefits predicted missing any work for child illness, missing >4 weeks for child illness, and ability to miss work whenever their child needed them.RESULTS. Forty-eight percent of full-time–employed parents qualified for federal Family and Medical Leave Act benefits; 30% reported employer-provided leave benefits (not including sick leave/vacation). In the previous year, their children averaged 20 missed school/child care days, 12 doctor/emergency department visits, and 1.7 hospitalizations. Although 81% of parents missed work for child illness, 41% reported not always missing work when their child needed them, and 40% of leave-takers reported returning to work too soon. In multivariate regressions, parents who were eligible for Family and Medical Leave Act benefits and aware of their eligibility had 3.0 times greater odds of missing work for child illness than ineligible parents. Parents with >4 weeks of employer-provided leave benefits had 4.7 times greater odds of missing >4 weeks than parents without benefits. Parents with paid leave benefits had 2.8 times greater odds than other parents of missing work whenever their child needed them.CONCLUSIONS. Full-time–employed parents of children with special health care needs experience severe work–family conflicts. Although most have leave benefits, many report unmet need for leave. Access to Family and Medical Leave Act benefits and employer-provided leave may greatly affect leave-taking.

1 February 2017 in American Economic Journal: Economic Policy
Verified
Journal Article
Closed access
PDF file
CCColleen Carey
Colleen Carey
Subsidized health insurance markets use diagnosis-based risk adjustment to induce insurers to offer an equitable benefit to individuals of varying expected cost. I demonstrate that technological change after risk adjustment calibration—new drug entry and the onset of generic competition—made certain diagnoses profitable or unprofitable in Medicare Part D. I then exploit variation in diagnoses' profitability driven by technological change to show insurers designed more favorable benefits for drugs that treat profitable diagnoses as compared to unprofitable diagnoses. In the presence of technological change, risk adjustment may not fully neutralize insurers' incentives to select through benefit designs. (JEL G22, H51, I13, I18, L65, O33)

3 February 2022 in Journal of Urban Health
Verified
Journal Article
Open access
PDF file
NDNicholas V. DiRago
Nicholas V. DiRago
MLMeiying Li
Meiying Li
TTThalia Tom
Thalia Tom
WSWill Schupmann
Will Schupmann
YCYvonne Carrillo
Yvonne Carrillo
SGS. Michael Gaddis
S. Michael Gaddis
Rollouts of COVID-19 vaccines in the USA were opportunities to redress disparities that surfaced during the pandemic. Initial eligibility criteria, however, neglected geographic, racial/ethnic, and socioeconomic considerations. Marginalized populations may have faced barriers to then-scarce vaccines, reinforcing disparities. Inequalities may have subsided as eligibility expanded. Using spatial modeling, we investigate how strongly local vaccination levels were associated with socioeconomic and racial/ethnic composition as authorities first extended vaccine eligibility to all adults. We harmonize administrative, demographic, and geospatial data across postal codes in eight large US cities over 3 weeks in Spring 2021. We find that, although vaccines were free regardless of health insurance coverage, local vaccination levels in March and April were negatively associated with poverty, enrollment in means-tested public health insurance (e.g., Medicaid), and the uninsured population. By April, vaccination levels in Black and Hispanic communities were only beginning to reach those of Asian and White communities in March. Increases in vaccination were smaller in socioeconomically disadvantaged Black and Hispanic communities than in more affluent, Asian, and White communities. Our findings suggest vaccine rollouts contributed to cumulative disadvantage. Populations that were left most vulnerable to COVID-19 benefited least from early expansions in vaccine availability in large US cities.